Everett Harris & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115M Sell
469,924
-7,297
-2% -$1.7M 1.48% 15
2025
Q4
$98.8M Sell
477,221
-2,235
-0.5% -$442K 1.19% 18
2025
Q3
$88.9M Sell
479,456
-5,055
-1% -$866K 1.1% 20
2025
Q2
$74M Sell
484,511
-8,388
-2% -$1.29M 0.95% 24
2025
Q1
$81.7M Sell
492,899
-27,886
-5% -$4.36M 1.05% 22
2024
Q4
$75.3M Sell
520,785
-7,062
-1% -$1.09M 0.95% 24
2024
Q3
$85.5M Sell
527,847
-6,737
-1% -$1.07M 1.06% 23
2024
Q2
$78.1M Sell
534,584
-16,725
-3% -$2.49M 1% 23
2024
Q1
$87.2M Sell
551,309
-8,351
-1% -$1.33M 1.16% 22
2023
Q4
$87.7M Sell
559,660
-16,853
-3% -$2.58M 1.25% 20
2023
Q3
$89.8M Sell
576,513
-34,110
-6% -$5.63M 1.4% 19
2023
Q2
$101M Sell
610,623
-180,659
-23% -$29.2M 1.53% 17
2023
Q1
$123M Sell
791,282
-40,464
-5% -$6.53M 1.99% 12
2022
Q4
$147M Sell
831,746
-15,561
-2% -$2.69M 2.53% 10
2022
Q3
$138M Sell
847,307
-16,628
-2% -$2.81M 2.55% 10
2022
Q2
$153M Sell
863,935
-16,040
-2% -$2.86M 2.65% 10
2022
Q1
$156M Sell
879,975
-2,648
-0.3% -$451K 2.22% 12
2021
Q4
$151M Sell
882,623
-886
-0.1% -$145K 2.09% 14
2021
Q3
$143M Sell
883,509
-4,269
-0.5% -$728K 2.26% 13
2021
Q2
$146M Sell
887,778
-2,171
-0.2% -$359K 2.34% 13
2021
Q1
$146M Sell
889,949
-11,425
-1% -$1.85M 2.54% 12
2020
Q4
$142M Buy
901,374
+7,483
+0.8% +$1.1M 2.51% 13
2020
Q3
$133M Buy
893,891
+2,026
+0.2% +$300K 2.6% 13
2020
Q2
$125M Buy
891,865
+4,395
+0.5% +$640K 2.77% 12
2020
Q1
$116M Buy
887,470
+67,056
+8% +$9.51M 3% 10
2019
Q4
$120M Buy
820,414
+6,495
+0.8% +$881K 2.7% 10
2019
Q3
$105M Buy
813,919
+17,645
+2% +$2.32M 2.6% 10
2019
Q2
$111M Sell
796,274
-2,969
-0.4% -$411K 2.78% 10
2019
Q1
$112M Sell
799,243
-94,647
-11% -$12.7M 2.9% 10
2018
Q4
$115M Sell
893,890
-25,017
-3% -$3.49M 3.28% 10
2018
Q3
$127M Sell
918,907
-15,111
-2% -$2.01M 3.18% 9
2018
Q2
$113M Sell
934,018
-5,713
-0.6% -$713K 3.09% 9
2018
Q1
$120M Buy
939,731
+28,246
+3% +$3.82M 3.34% 8
2017
Q4
$127M Sell
911,485
-2,073
-0.2% -$289K 3.55% 8
2017
Q3
$119M Sell
913,558
-2,504
-0.3% -$332K 3.57% 7
2017
Q2
$121M Sell
916,062
-204
-0% -$26K 3.75% 8
2017
Q1
$114M Sell
916,266
-7,070
-0.8% -$845K 3.73% 7
2016
Q4
$106M Sell
923,336
-3,358
-0.4% -$388K 3.74% 8
2016
Q3
$109M Sell
926,694
-22,693
-2% -$2.75M 3.87% 7
2016
Q2
$115M Sell
949,387
-2,855
-0.3% -$324K 4.11% 6
2016
Q1
$103M Buy
952,242
+2,595
+0.3% +$269K 3.7% 8
2015
Q4
$97.5M Sell
949,647
-6,514
-0.7% -$655K 3.41% 8
2015
Q3
$89.3M Sell
956,161
-41
-0% -$3.97K 3.27% 7
2015
Q2
$93.2M Sell
956,202
-1,955
-0.2% -$196K 3.27% 8
2015
Q1
$96.4M Buy
958,157
+1,587
+0.2% +$161K 3.3% 8
2014
Q4
$100M Buy
956,570
+2,115
+0.2% +$223K 3.42% 6
2014
Q3
$102M Buy
954,455
+3,888
+0.4% +$403K 3.67% 6
2014
Q2
$99.4M Sell
950,567
-12,507
-1% -$1.26M 3.67% 6
2014
Q1
$94.6M Buy
963,074
+3,520
+0.4% +$326K 3.52% 8
2013
Q4
$87.9M Buy
959,554
+17,065
+2% +$1.57M 3.28% 9
2013
Q3
$81.7M Buy
942,489
+2,955
+0.3% +$265K 3.33% 9
2013
Q2
$80.7M Buy
+939,534
New +$79.7M 3.36% 8

Other funds holding JNJ

Everett Harris & Co's JNJ Position: Q1 2026 in Review

Everett Harris & Co reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, selling an estimated $1.7M and leaving 469,924 shares worth $115M. The position accounts for 1.48% of the portfolio, ranked #15.

Everett Harris & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $156M in Q1 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Everett Harris & Co held 469,924 shares of Johnson & Johnson worth $115M as of Q1 2026.
  • Everett Harris & Co sold 7,297 Johnson & Johnson shares in Q1 2026, an estimated $1.7M.
  • Johnson & Johnson made up 1.48% of Everett Harris & Co's portfolio in Q1 2026, its #15 holding.
  • Everett Harris & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Everett Harris & Co's Johnson & Johnson position peaked at $156M in Q1 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Everett Harris & Co's 13F filing for Q1 2026, filed 11 May 2026.